← Back to Search

Decision Aid for Thyroid Cancer

N/A
Recruiting
Led By Elizabeth G Grubbs
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years old or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Study Summary

This trial is studying how well a patient decision aid works in supporting decision-making about cancer care for patients with medullary thyroid cancer and their caregivers.

Who is the study for?
This trial is for adults with medullary thyroid cancer and their caregivers. Participants must be able to communicate in English, and pregnant patients can join. It's also open to healthcare providers treating this condition. People with cognitive or psychological impairments are not eligible.Check my eligibility
What is being tested?
The study is testing a decision aid designed to help patients and caregivers make informed choices about starting or stopping medications, joining clinical trials, or continuing with active monitoring of medullary thyroid cancer.See study design
What are the potential side effects?
Since the intervention involves questionnaire administration and use of a decision aid, there are no direct medical side effects associated with typical drug treatments; however, participants may experience stress or emotional discomfort while making decisions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decision aid acceptability
Decision aid design refining (storyboarding)
Needs assessment
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (decision aid)Experimental Treatment2 Interventions
Participants use decision aid and complete questionnaires.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,973 Previous Clinical Trials
1,789,201 Total Patients Enrolled
1 Trials studying Thyroid Carcinoma
3,400 Patients Enrolled for Thyroid Carcinoma
National Cancer Institute (NCI)NIH
13,664 Previous Clinical Trials
40,926,013 Total Patients Enrolled
Elizabeth G GrubbsPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
2,030 Total Patients Enrolled

Media Library

Decision Aid Clinical Trial Eligibility Overview. Trial Name: NCT03892993 — N/A
Thyroid Carcinoma Research Study Groups: Supportive care (decision aid)
Thyroid Carcinoma Clinical Trial 2023: Decision Aid Highlights & Side Effects. Trial Name: NCT03892993 — N/A
Decision Aid 2023 Treatment Timeline for Medical Study. Trial Name: NCT03892993 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation currently recruiting participants?

"Affirmative, clinicaltrials.gov lists this medical trial as actively searching for participants. It was initially posted on April 9th 2019 and has been recently revised on July 14th 2022. The total number of needed individuals is 120 across one primary location."

Answered by AI

How many individuals may partake in this clinical research?

"Correct. The clinical trial is actively seeking out participants, as stated on the information hosted on clinicaltrials.gov; it was initially posted on April 9th 2019 and most recently updated July 14th 2022. One medical site needs to recruit 120 patients for this project."

Answered by AI

Who else is applying?

What state do they live in?
South Carolina
Kansas
How old are they?
18 - 65
What site did they apply to?
M D Anderson Cancer Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers
2019. "Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03892993.
All > Thyroid Cancer > Medullary Thyroid Cancer
~55 spots leftby Aug 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top